Evidence map›Paper›PMID 26172445›Full record

ArticlePloS one2015

Periluminal Distribution of HIV-Binding Target Cells and Gp340 in the Oral, Cervical and Sigmoid/Rectal Mucosae: A Mapping Study.

Mariia Patyka, Daniel Malamud, Drew Weissman, William R Abrams, Zoya Kurago

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Human Semen or Seminal Plasma Does Not Enhance HIV-1AIDS research and human retroviruses · 2018
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Mariia PatykaFaculty of Medicine, Division of Experimental Medicine, McGill University, Montreal, Quebec, Canada.
Daniel MalamudNYU College of Dentistry, Department of Basic Sciences, HIV/AIDS Research Program (HARP), New York, New York, United States of America; NYU School of Medicine, Infectious Disease, New York, New York, United States of America.
Drew WeissmanMedicine (Infectious Disease), Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
William R AbramsNYU College of Dentistry, Department of Basic Sciences, HIV/AIDS Research Program (HARP), New York, New York, United States of America.
Zoya KuragoOral Health and Diagnostic Sciences, College of Dental Medicine, Georgia Regents University, Augusta, Georgia, United States of America.
New York College of Health Professions · USAugusta University · USMcGill University · CAUniversity of Pennsylvania · US

Funding

Project-005UL1TR001445 · NCATS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BREDELLA, MIRIAM ANTOINETTE, HOCHMAN, JUDITH S · 2015 to 2025
$103.5M
Vaccine FacilityP30CA016087 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ANIRBAN MAITRA · 1985 to 2026
$83.1M
Virus & Reservoirs CoreP30AI045008 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI DAVID S METZGER · 1999 to 2026
$78.6M
INSTITUTIONAL CLINICAL AND TRANSLATIONAL SCIENCE AWARDUL1RR029893 · NCRR · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CRONSTEIN, BRUCE NEIL · 2009 to 2011
$17.7M
The Proteomic and Functional Profile of HIV Positive SalivaU19DE018385 · NIDCR · NEW YORK UNIVERSITY · PI MALAMUD, DANIEL · 2007 to 2014
$6.6M
The Role of Scavenger Receptor gp340 in Mucosal HIV-1 Transmission and InhibitionR01AI094599 · NIAID · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI LU, MIN, MALAMUD, DANIEL · 2011 to 2016
$3.9M
Gp340 and syndecan inhibition based microbicide for HIVR33AI082701 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI WEISSMAN, DREW · 2012 to 2014
$1.4M
Gp340 and syndecan inhibition based microbicide for HIVR21AI082701 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI WEISSMAN, DREW · 2009 to 2010
$437k
NCATS NIH HHS UL1 TR001445NCI NIH HHS 5P30CA016087-32NCI NIH HHS P30 CA016087NCRR NIH HHS UL1 RR029893NCRR NIH HHS UL1RR029893NIAID NIH HHS AI082701NIAID NIH HHS AI094599NIAID NIH HHS P30 AI045008NIAID NIH HHS R01 AI094599NIAID NIH HHS R21 AI082701NIAID NIH HHS R33 AI082701NIDCR NIH HHS U19 DE018385NIDCR NIH HHS U19DE018385
6 · The paper itself

Abstract

Studies have shown that the transmission of HIV is most likely to occur via rectal or vaginal routes, and rarely through oral exposure. However, the mechanisms of virus entry at mucosal surfaces remain incompletely understood. Prophylactic strategies against HIV infection may be attainable once gaps in current knowledge are filled. To address these gaps, we evaluated essentially normal epithelial surfaces and mapped the periluminal distribution of CD4+ HIV target cells, including T cells and antigen-presenting cells, and an HIV-binding molecule gp340 that can be expressed by epithelial cells in secreted and cell-associated forms. Immunohistochemistry for CD4, CD16, CD3, CD1a and gp340 in human oral, rectal/sigmoid and cervical mucosal samples from HIV-negative subjects demonstrated that periluminal HIV target cells were more prevalent at rectal/sigmoid and endocervical surfaces lined by simple columnar epithelium, than at oral and ectocervical surfaces covered by multilayered stratified squamous epithelium (p<0.001). gp340 expression patterns at these sites were also distinct and strong in oral minor salivary gland acini and ducts, including ductal saliva, in individual rectum/sigmoid and endocervix periluminar columnar cells, and in ectocervix squamous cells. Only weak expression was noted in the oral non-ductal squamous epithelium. We conclude that periluminal HIV target cells, together with periluminal epithelial cell-associated gp340 appear to be most accessible for HIV transmission at rectal/sigmoid and endocervical surfaces. Our data help define vulnerable structural features of mucosal sites exposed to HIV.

Indexed as

Antigen-Presenting CellsCalcium-Binding ProteinsCD4-Positive T-LymphocytesCervix UteriColon, SigmoidDNA-Binding ProteinsEpithelial CellsEpitheliumFemaleHIVHIV InfectionsHumansMucous MembraneReceptors, Cell SurfaceRectumTumor Suppressor ProteinsCalcium-Binding ProteinsDMBT1 protein, humanDNA-Binding ProteinsReceptors, Cell SurfaceTumor Suppressor Proteins

Identifiers

PMID26172445
PMCPMC4501766
OpenAlexW1435968215

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.